J 2014

Xanthelasma palpebrarum responding to interleukin-1 blockade

SZTURZ, Petr; Zdeněk ADAM; Z. ŘEHÁK and Renata KOUKALOVÁ

Basic information

Original name

Xanthelasma palpebrarum responding to interleukin-1 blockade

Authors

SZTURZ, Petr (203 Czech Republic, guarantor, belonging to the institution); Zdeněk ADAM (203 Czech Republic, belonging to the institution); Z. ŘEHÁK (203 Czech Republic) and Renata KOUKALOVÁ (203 Czech Republic)

Edition

Internal medicine journal, Hoboken, Wiley-Blackwell, 2014, 1444-0903

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United States of America

Confidentiality degree

is not subject to a state or trade secret

Impact factor

Impact factor: 1.644

RIV identification code

RIV/00216224:14110/14:00076145

Organization unit

Faculty of Medicine

DOI

UT WoS

000337966800018

EID Scopus

2-s2.0-84904645194

Keywords in English

xanthelasma palpebrarum; Erdheim–Chester disease; anakinra

Tags

Tags

International impact, Reviewed
Changed: 29/11/2016 15:03, Soňa Böhmová

Abstract

V originále

Darstein et al. presented an interesting case of a 45-yearold man diagnosed with Erdheim–Chester disease (ECD), a rare non-Langerhans cell histiocytosis characterised by proliferation and accumulation of lipid laden foamy histiocytes. Subsequently, the patient was successfully treated with combination of anakinra (interleukin-1 receptor antagonist) and glucocorticoids.1 We draw readers’ attention to xanthelasma palpebrarum as a common manifestation of ECD.